Phil Proger, a Partner in Jones Day's Washington, D.C., office, practices antitrust law with emphasis on matters before U.S. and international enforcement agencies, including mergers and cartel investigations, as well as antitrust litigation. Mr. Proger has extensive experience advising on antitrust issues in a broad range of industries, including health care, chemicals, insurance, media, pharmaceuticals, software, and retail.
He has represented companies and individuals in criminal and civil cartel investigations conducted simultaneously in multiple jurisdictions and defended those clients in follow-up class actions, private treble damage actions, and non-U.S. damage actions. He also has handled numerous investigations by antitrust enforcement agencies involving mergers and nonmerger conduct (including conduct involving licensing, patent settlements, and refusals to deal).
Mr. Proger has served as a member of the Board of Governors of the American Bar Association, Chair of the ABA Section of Antitrust Law, and Co-Chair of the ABA's 2008 Transition Report to the new Administration on antitrust enforcement. He is a frequent writer and speaker on antitrust topics and has testified before Congress (Senate and House of Representatives), the Federal Trade Commission, the Antitrust Modernization Commission, and the International Competition Policy Advisory Committee. He is a Fellow of the American Bar Foundation, the advisory boards of BNA Antitrust & Trade Regulation Report and The M&A Lawyer, and the Board of Visitors of the University of Maryland School of Law.
Mr. Proger received his B.A. and his J.D from the University of Maryland.
He is a co-author of the Bloomberg BNA Health Law & Business Portfolio Series No. 2500, Health Care Networks and Managed Care: Antitrust Aspects of Integration and Exclusion.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)